AKO Capital's position in Illumina is currently worth $39.4 Million. That's 0.54% of their equity portfolio (24th largest holding). The investor's estimated purchase price is $70.5 Million, resulting in a loss of 44%.
On June 25, 2024, Illumina, Inc. (NASDAQ: ILMN, $208.92, Market Capitalization: $18.51 billion) announced the completion of the tax free spin-off of GRAIL, I...
On June 3, 2024, Illumina's (NASDAQ: ILMN, $109.82, Market Capitalization: $17.5 billion) board of directors approved the spin-off of its wholly owned subsid...
Illumina, Inc. (NASDAQ:NASDAQ:ILMN) RBC Capital Markets Global Healthcare Call May 14, 2024 8:30 AM ETCompany ParticipantsAnkur Dhingra - Chief Financial…
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2023 investor letter. A copy of...